Osaic Holdings
RIGL icon

Osaic Holdings’s Rigel Pharmaceuticals RIGL Stock Holding History

Osaic Holdings’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$436K Sell
11,157
-3,051
-21% -$94.1K ﹤0.01% 3772
2026
Q1 		$384K Buy
14,208
+5,672
+66% +$191K ﹤0.01% 3607
2025
Q4 		$365K Buy
8,536
+7,839
+1,125% +$296K ﹤0.01% 3622
2025
Q3 		$23.2K Buy
697
+289
+71% +$8.64K ﹤0.01% 5834
2025
Q2 		$7.64K Buy
408
+168
+70% +$3.19K ﹤0.01% 6316
2025
Q1 		$4.32K Sell
240
-260
-52% -$5.28K ﹤0.01% 6255
2024
Q4 		$8.41K Hold
500
– – ﹤0.01% 5897
2024
Q3 		$8.09K Buy
500
+340
+213% +$4K ﹤0.01% 5943
2024
Q2 		$1.31K Sell
160
-181
-53% -$1.9K ﹤0.01% 6740
2024
Q1 		$5.04K Hold
341
– – ﹤0.01% 6085
2023
Q4 		$4.94K Buy
341
+200
+142% +$2.04K ﹤0.01% 6182
2023
Q3 		$1.52K Hold
141
– – ﹤0.01% 6716
2023
Q2 		$1.81K Hold
141
– – ﹤0.01% 6702
2023
Q1 		$1.85K Hold
141
– – ﹤0.01% 6746
2022
Q4 		$2K Hold
141
– – ﹤0.01% 6700
2022
Q3 		$2K Hold
141
– – ﹤0.01% 6818
2022
Q2 		$2K Hold
141
– – ﹤0.01% 6926
2022
Q1 		$4K Hold
141
– – ﹤0.01% 6631
2021
Q4 		$4K Sell
141
-10
-7% -$302 ﹤0.01% 6773
2021
Q3 		$5K Buy
151
+10
+7% +$394 ﹤0.01% 6545
2021
Q2 		$6K Hold
141
– – ﹤0.01% 6306
2021
Q1 		$5K Hold
141
– – ﹤0.01% 6172
2020
Q4 		$5K Sell
141
-900
-86% -$26.1K ﹤0.01% 5790
2020
Q3 		$24K Sell
1,041
-150
-13% -$3.68K ﹤0.01% 4819
2020
Q2 		$22K Buy
1,191
+608
+104% +$10.9K ﹤0.01% 4745
2020
Q1 		$9K Buy
+583
New +$12.4K ﹤0.01% 5076

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's RIGL Position: Q2 2026 in Review

Osaic Holdings reduced its Rigel Pharmaceuticals (RIGL) stake by 21% in Q2 2026, selling an estimated $94.1K and leaving 11,157 shares worth $436K. The position accounts for ﹤0.01% of the portfolio, ranked #3772.

Osaic Holdings first reported a position in RIGL in Q1 2020 and has held it in 26 quarters since. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Osaic Holdings held 11,157 shares of Rigel Pharmaceuticals worth $436K as of Q2 2026.
  • Osaic Holdings sold 3,051 Rigel Pharmaceuticals shares in Q2 2026, an estimated $94.1K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3772 holding.
  • Osaic Holdings first reported a position in Rigel Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.